Japan's Ono Pharmaceutical rises after report of plan to expand use of cancer drug

ONO PHARMACEUTICAL

19/03/2018 01:15

** Shares of Ono Pharmaceutical Co Ltd  4528.T  rise 1.3 pct
to 3,272 yen, outperforming overall market, with Nikkei index
 .N225  down 1.2 pct
    ** Company plans to expand use of cancer treatment drug
Opdivo, Nikkei daily reports, citing president 
    ** Opdivo currently treats six types of cancer, with health
ministry approval sought for expansion to treat four other types
of cancer - Nikkei daily
    ** Up to last close, stock had risen 23.04 pct this year
    ** As of 0101 GMT, about 724,200 shares have been traded,
compared woth their 30-day moving average of 2.87 million shares
a day
    ** Among the 13 analysts that cover stock, the current
average rating on the shares is "buy", with 9 "strong buy" or
"buy" and four "hold"; mean price target is 3,173.33 yen

 ((Reuters
Messaging:ayai.tomisawa.thomsonreuters.com@reuters.net))